Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Deoxyamidinoproclavaminic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002016 AN003284 Metabolomics of COVID patients Blood Human COVID-19 University of Virginia intensity
ST002775 AN004517 Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Normalized Concentrations
ST002444 AN003981 Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami normalized peak areas
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Bacillus megaterium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut peak area
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Enterococcus faecium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut peak area
ST000291 AN000465 LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice Urine Human University of Florida Peak area
ST002792 AN004542 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University peak height
ST003024 AN004958 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 Bacterial cells Bacteria Monash Institute of Pharmaceutical Sciences peak height
ST003036 AN004978 Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 Bacterial cells Pseudomonas aeruginosa Bacterial infection Monash Institute of Pharmaceutical Sciences peak height
ST003053 AN005007 Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics Bacterial cells Staphylococcus aureus Bacterial infection Monash University peak height
ST003144 AN005159 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University peak height
ST003521 AN005782 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University peak height
ST003521 AN005783 Metabolic Profiling Unveils Enhanced Antibacterial Synergy of Polymyxin B and Teixobactin against Multi-Drug Resistant Acinetobacter baumannii Bacterial cells Acinetobacter baumannii Bacterial infection Monash University peak height
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST002108 AN003448 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University relative intensity
  logo